Raltitrexed-based transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:a285074984
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Purpose: We aimed to evaluate the efficacy and safety of transcatheter arterial chemoembolization(TACE),a combination of raltitrexed,oxaliplatin,and epirubicin,for unresectable hepatocellular carcinoma(HCC).
其他文献
Objective: To evaluate the changes of normal miniature pig kidney imaging and pathological after ablation of Nanoknife.
Purpose: To observe the efficacy and safety of sorafenib for advanced hepatocellular carcinoma with TACE refractoriness.
Hepatic metastases develop in 85%of patients with gastroenteropancreatic neuroendocrine tumors.
Objective: To evaluate the feasibility and efficacy of transactheter arterial chemoembolization(TACE)by collateral arteries due to common hepatic artery(CHA)occlusion.
Objective: To evaluate the therapeutic efficacy and safety of transarterial infusion(TAI)with gemcitabine and oxaliplatin in patients with unresectable pancreatic cancer(PC).
Purpose: To evaluate the effectiveness and to follow-up the results of arterial embolization of adrenal tumors.
Purpose: Borden type Ⅲ Intracranial dural arteriovenous fistulas(DAVFs)carry a high risk of aggressive clinical manifestations,which require curative treatment.